New PKU nighttime treatment tested for better blood control
Disease control
Completed
This study tested if a new protein substitute called PKU GOLIKE, taken at night, helps keep blood phenylalanine levels more stable in children with PKU compared to their standard amino acid treatment. Sixteen children tried both treatments for one week each, with a break in betwe…
Phase: NA • Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC